Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Visual hallucinations in PD and Lewy body dementias: old and new hypotheses 2013-01-01
  2. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses 2007-01-17

Studies

2 studies carry this tag.

Date range

2007 to 2013

Top journals

  • Behavioural neurology 1
  • The Journal of pharmacology and experimental therapeutics 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Visual hallucinations in PD and Lewy body dementias: old and new hypotheses

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Behavioural neurology 2013-01-01 Brain scans and imaging

    Visual Hallucinations (VH) are a common non-motor symptom of Parkinson's Disease (PD) and the Lewy body dementias (LBD) of Parkinson's disease with dementia (PDD) and Dementia with Lewy Bodies (DLB).

  2. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of pharmacology and experimental therapeutics 2007-01-17 Drug development

    For nearly 20 years, the primary focus for researchers studying Alzheimer disease has been centered on amyloid-beta, such that the amyloid cascade hypothesis has become the "null hypothesis."

All topic tags with their study counts